EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP

Chen Mu iD, Han Zhang iD

Turkish Journal of Gastroenterology · 21.07.2026

DOI: 10.5152/tjg.2026.26198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, online erschienen am 21.07.2026. Verfasst von Chen Mu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: miR-143-5p functions as a tumor-suppressive microRNA across various cancer types. The current study investigated the expression, prognostic value, and role of miR-143-5p in colorectal cancer (CRC). Materials and Methods: The expression of miR-143-5p was measured by quantitative reverse transcription polymerase chain reaction. Associations between miR-143-5p expression and clinicopathological characteristics of patients with CRC were statistically analyzed. A series of in vitro cell-based assays were performed to investigate the underlying regulatory mechanisms. Results: miR-143-5p was downregulated in CRC and may serve as a promising independent prognostic biomarker. Reduced miR- 143-5p expression was associated with adverse clinicopathological characteristics and decreased 5-year overall survival. MYCBP was identified as a direct target of miR-143-5p. Overexpression of miR-143-5p suppressed the malignant behaviors of CRC cells, which were partially restored by enforced MYCBP expression. Conclusion: miR-143-5p is downregulated in CRC and may function as a potential independent prognostic biomarker. Moreover, miR- 143-5p may play a tumor-suppressive role in CRC by specifically targeting MYCBP. Cite this article as: Mu C, Zhang H. MiR-143-5p as a prognostic biomarker in colorectal cancer: Inhibition of tumor progression through targeting MYCBP. Turk J Gastroenterol. Published online July 21, 2026. doi: 10.5152/tjg.2026.26198.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerMYCBPcolorectal cancermechanismmiR-143-5p

Autor:innen und Institutionen

  • Department of Gastroenterology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pulmonary and Critical Care Medicine, The Eighth Medical Center of PLA General Hospital, Beijing, China.

ORCID-Profile: Chen Mu, Han Zhang

Zitieren

APA

Mu, C., & Zhang, H. (2026). miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2026.26198

Vancouver

Mu C, Zhang H. miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP. Turkish Journal of Gastroenterology. 2026. doi:10.5152/tjg.2026.26198

BibTeX
@article{Mu2026,
  author = {Mu, Chen and Zhang, Han},
  title = {miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP},
  journal = {Turkish Journal of Gastroenterology},
  year = {2026},
  doi = {10.5152/tjg.2026.26198}
}
Kostenlos starten →